BariatricNurseD said:Dr.DermMIA said: ...regarding the discontinuation data for cost and coverage...
Mine went the same way, slower.
BariatricNurseD said:Dr.DermMIA said: ...regarding the discontinuation data for cost and coverage...
Mine went the same way, slower.
BariatricNurseD said:Dr.DermMIA said: ...regarding the discontinuation data for cost and coverage...
Coming at BariatricNurseD’s question from a different direction. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.
Ask again with the specifics and you will get a better answer than this one.
Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.
Worth separating that from vendor vetting, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesEst. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemFollowing on from BariatricNurseD — and this may be the naive question:
Did your prescriber agree with that reading, and if not what was their objection?
Closing the loop on my own question.
Follow-up — getting the denial reason in writing was the step that mattered. It named the criterion, and the criterion was a document I already had.